{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:04:01Z","timestamp":1779800641263,"version":"3.53.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM2HD111102"],"award-info":[{"award-number":["UM2HD111102"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM2HD111102"],"award-info":[{"award-number":["UM2HD111102"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM2HD111076"],"award-info":[{"award-number":["UM2HD111076"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["UM2HD111076"],"award-info":[{"award-number":["UM2HD111076"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"DOI":"10.1007\/s10461-026-05155-w","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:53:24Z","timestamp":1779792804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review of Remote Biospecimen Collection Product and Implementation Considerations for Sexual Health Clinical Research"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-2839","authenticated-orcid":false,"given":"Keith J.","family":"Horvath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1571-6576","authenticated-orcid":false,"given":"Sarah E.","family":"Rutstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-7020","authenticated-orcid":false,"given":"Ryan P.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3508-5350","authenticated-orcid":false,"given":"Cheryl","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6995-1543","authenticated-orcid":false,"given":"Rahim Z.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1669-6455","authenticated-orcid":false,"given":"Justin","family":"Unternaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-7632","authenticated-orcid":false,"given":"Kelly","family":"Bojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1604-9637","authenticated-orcid":false,"given":"Grace M.","family":"Aldrovandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4458-6934","authenticated-orcid":false,"given":"K. Rivet","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-8494","authenticated-orcid":false,"given":"Peter L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8466-1628","authenticated-orcid":false,"given":"Nadia","family":"Dowshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-0759","authenticated-orcid":false,"given":"Sybil","family":"Hosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2421-923X","authenticated-orcid":false,"given":"Lisa","family":"Hightow-Weidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-8786","authenticated-orcid":false,"given":"Mark A.","family":"Marzinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"11","key":"5155_CR1","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1007\/s10461-024-04453-5","volume":"28","author":"JE Diaz","year":"2024","unstructured":"Diaz JE, et al. Challenges and Opportunities with at-Home Blood Collection for HIV-1 Viral Load Monitoring among Sexual Minoritized Men who use Stimulants. AIDS Behav. 2024;28(11):3809\u201318.","journal-title":"AIDS Behav"},{"key":"5155_CR2","doi-asserted-by":"publisher","first-page":"e43539","DOI":"10.2196\/43539","volume":"7","author":"G Sallabank","year":"2023","unstructured":"Sallabank G, et al. Lessons Learned From the Implementation of a Pilot Study on Self-collected Specimen Return by Sexual Minority Men (Project Caboodle!): Qualitative Exploration. JMIR Form Res. 2023;7:e43539.","journal-title":"JMIR Form Res"},{"issue":"3","key":"5155_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/cpt.2801","volume":"113","author":"LR Cirrincione","year":"2023","unstructured":"Cirrincione LR, et al. Inclusion of transgender and gender diverse people in phase III trials: examples from HIV pharmacologic prevention studies. Clin Pharmacol Ther. 2023;113(3):557\u201364.","journal-title":"Clin Pharmacol Ther"},{"issue":"2s","key":"5155_CR4","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1097\/QAI.0000000000003265","volume":"94","author":"WC Irie","year":"2023","unstructured":"Irie WC, et al. Pathways and Intersections: Multifaceted Approaches to Engage Individuals From Underrepresented and Marginalized Communities in HIV Research and Career Development. J Acquir Immune Defic Syndr. 2023;94(2s):S116\u201321.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"5155_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/25787489.2022.2103582","volume":"23","author":"K Dub\u00e9","year":"2022","unstructured":"Dub\u00e9 K, et al. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions. HIV Res Clin Pract. 2022;23(1):76\u201390.","journal-title":"HIV Res Clin Pract"},{"issue":"2","key":"5155_CR6","doi-asserted-by":"publisher","first-page":"ofab657","DOI":"10.1093\/ofid\/ofab657","volume":"9","author":"P Saberi","year":"2022","unstructured":"Saberi P, et al. Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics. Open Forum Infect Dis. 2022;9(2):ofab657.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"5155_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/sextrans-2024-056386","volume":"101","author":"C Oeser","year":"2025","unstructured":"Oeser C, et al. Home-based self-collection of biological samples, including vaginal swabs: a mixed methods study for Britain\u2019s fourth National Survey of Sexual Attitudes and Lifestyles (Natsal-4). Sex Transm Infect. 2025;101(4):252\u20135.","journal-title":"Sex Transm Infect"},{"key":"5155_CR8","unstructured":"I Want the Kit. 2025 [cited 2025 December 4]. Available from: https:\/\/iwantthekit.org"},{"issue":"6","key":"5155_CR9","doi-asserted-by":"publisher","first-page":"e37479","DOI":"10.2196\/37479","volume":"8","author":"P Patel","year":"2022","unstructured":"Patel P, et al. Public health implications of adapting HIV pre-exposure prophylaxis programs for virtual service delivery in the context of the COVID-19 pandemic: systematic review. JMIR Public Health Surveill. 2022;8(6):e37479.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"5155_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12981-022-00496-7","volume":"20","author":"S SeyedAlinaghi","year":"2023","unstructured":"SeyedAlinaghi S, et al. The impacts of COVID-19 pandemic on service delivery and treatment outcomes in people living with HIV: a systematic review. AIDS Res Ther. 2023;20(1):4.","journal-title":"AIDS Res Ther"},{"issue":"6","key":"5155_CR11","doi-asserted-by":"publisher","first-page":"e12931","DOI":"10.1111\/eci.12931","volume":"48","author":"T Greenhalgh","year":"2018","unstructured":"Greenhalgh T, Thorne S, Malterud K. Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest. 2018;48(6):e12931.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"5155_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0899-3467(07)60142-6","volume":"5","author":"BN Green","year":"2006","unstructured":"Green BN, Johnson CD, Adams A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006;5(3):101\u201317.","journal-title":"J Chiropr Med"},{"issue":"1","key":"5155_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s12889-025-21773-w","volume":"25","author":"AJ Borek","year":"2025","unstructured":"Borek AJ, et al. Acceptability of self-sampling and self-testing for infections: a rapid systematic review on public users\u2019 views. BMC Public Health. 2025;25(1):695.","journal-title":"BMC Public Health"},{"issue":"6","key":"5155_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/jcp.2011.090332","volume":"64","author":"D Haarburger","year":"2011","unstructured":"Haarburger D, Pillay TS. Historical perspectives in diagnostic clinical pathology: development of the pregnancy test. J Clin Pathol. 2011;64(6):546\u20138.","journal-title":"J Clin Pathol"},{"issue":"2","key":"5155_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/bios13020298","volume":"13","author":"A Bacon","year":"2023","unstructured":"Bacon A, et al. Review of HIV self testing technologies and promising approaches for the next generation. Biosens (Basel). 2023;13(2):298.","journal-title":"Biosens (Basel)"},{"key":"5155_CR16","doi-asserted-by":"publisher","first-page":"594298","DOI":"10.3389\/fpubh.2021.594298","volume":"9","author":"A Hamilton","year":"2021","unstructured":"Hamilton A, et al. HIV Self-Testing Uptake and Intervention Strategies Among Men in Sub-Saharan Africa: A Systematic Review. Front Public Health. 2021;9:594298.","journal-title":"Front Public Health"},{"key":"5155_CR17","doi-asserted-by":"publisher","first-page":"103613","DOI":"10.1016\/j.drugpo.2022.103613","volume":"103","author":"NC Peiper","year":"2022","unstructured":"Peiper NC, et al. Acceptability of a HIV self-testing program among people who use illicit drugs. Int J Drug Policy. 2022;103:103613.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"5155_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QAI.0000000000001709","volume":"78","author":"DA Katz","year":"2018","unstructured":"Katz DA, et al. HIV self-testing increases HIV testing frequency in high-risk men who have sex with men: a randomized controlled trial. J Acquir Immune Defic Syndr. 2018;78(5):505\u201312.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"5155_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamainternmed.2019.5222","volume":"180","author":"RJ MacGowan","year":"2020","unstructured":"MacGowan RJ, et al. Effect of Internet-distributed HIV self-tests on hiv diagnosis and behavioral outcomes in men who have sex with men: a randomized clinical trial. JAMA Intern Med. 2020;180(1):117\u201325.","journal-title":"JAMA Intern Med"},{"issue":"10326","key":"5155_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(21)02346-1","volume":"399","author":"RW Peeling","year":"2022","unstructured":"Peeling RW, et al. Diagnostics for COVID-19: moving from pandemic response to control. Lancet. 2022;399(10326):757\u201368.","journal-title":"Lancet"},{"issue":"1","key":"5155_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/cclm-2024-0508","volume":"63","author":"DCW Poland","year":"2025","unstructured":"Poland DCW, Cobbaert CM. Blood self-sampling devices: innovation, interpretation and implementation in total lab automation. Clin Chem Lab Med. 2025;63(1):3\u201313.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"5155_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.clinmicnews.2023.02.001","volume":"45","author":"RC Fyffe-Freil","year":"2023","unstructured":"Fyffe-Freil RC, Jannetto PJ, Vanderboom PM. To boldly go where no device has gone before: specimen self-collection for the clinical laboratory. Clin Microbiol Newsl. 2023;45(4):29\u201337.","journal-title":"Clin Microbiol Newsl"},{"issue":"8","key":"5155_CR23","doi-asserted-by":"publisher","first-page":"e1004076","DOI":"10.1371\/journal.pmed.1004076","volume":"19","author":"L Vojnov","year":"2022","unstructured":"Vojnov L, et al. The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis. PLoS Med. 2022;19(8):e1004076.","journal-title":"PLoS Med"},{"issue":"4","key":"5155_CR24","first-page":"195","volume":"12","author":"S Bertagnolio","year":"2010","unstructured":"Bertagnolio S, et al. Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev. 2010;12(4):195\u2013208.","journal-title":"AIDS Rev"},{"issue":"7","key":"5155_CR25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3851\/IMP1660","volume":"15","author":"A Johannessen","year":"2010","unstructured":"Johannessen A, et al. HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania. Antivir Ther. 2010;15(7):1003\u20139.","journal-title":"Antivir Ther"},{"key":"5155_CR26","doi-asserted-by":"publisher","first-page":"115307","DOI":"10.1016\/j.jpba.2023.115307","volume":"228","author":"ED Weld","year":"2023","unstructured":"Weld ED, et al. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots. J Pharm Biomed Anal. 2023;228:115307.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"5155_CR27","doi-asserted-by":"publisher","first-page":"e01710","DOI":"10.1128\/AAC.01710-17","volume":"62","author":"PL Anderson","year":"2018","unstructured":"Anderson PL, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2018;62(1):e01710\u201317.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"5155_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000002354","volume":"84","author":"J Yager","year":"2020","unstructured":"Yager J, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following tenofovir alafenamide: the TAF-DBS study. J Acquir Immune Defic Syndr. 2020;84(3):323\u201330.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"5155_CR29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/cid\/ciae212","volume":"79","author":"RP Coyle","year":"2024","unstructured":"Coyle RP, et al. Tenofovir-diphosphate and emtricitabine-triphosphate adherence benchmarks in dried blood spots for persons with HIV receiving tenofovir alafenamide and emtricitabine-based antiretroviral therapy (QUANTI-TAF). Clin Infect Dis. 2024;79(5):1233\u201341.","journal-title":"Clin Infect Dis"},{"key":"5155_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","volume":"122","author":"JH Zheng","year":"2016","unstructured":"Zheng JH, et al. Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. J Pharm Biomed Anal. 2016;122:16\u201320.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"5155_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/QAI.0000000000003715","volume":"100","author":"PL Anderson","year":"2025","unstructured":"Anderson PL, et al. Recommendations for interpreting intraerythrocytic tenofovir diphosphate and emtricitabine triphosphate for HIV-1 preexposure prophylaxis adherence assessment. J Acquir Immune Defic Syndr. 2025;100(2):162\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5155_CR32","unstructured":"United States Postal Service. 600 Basic Standards for All Mailing Services. Mailing Standards of the United States Postal Service Domestic Mail Manual, 17 Dec 2025]. Available from: http:\/\/pe.usps.gov\/text\/dmm300\/601.htm#1065177"},{"key":"5155_CR33","unstructured":"Code of Federal Regulations. 49\u00a0C.F.R. 173.134. 1990."},{"key":"5155_CR34","unstructured":"United States Postal Service. Nonregulated Infectious Materials. 2026 [cited 2026 March 6]. Available from: https:\/\/pe.usps.com\/text\/pub52\/pub52apxc_023.htm"},{"key":"5155_CR35","unstructured":"United States Postal Service. Exempt Human or Animal Specimens. 2026 [cited 2026 March 6]. Available from: https:\/\/pe.usps.com\/text\/pub52\/pub52apxc_024.htm#ep1000503"},{"issue":"6","key":"5155_CR36","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00216-014-8415-2","volume":"407","author":"RA Koster","year":"2015","unstructured":"Koster RA, et al. Dried blood spot analysis of creatinine with LC-MS\/MS in addition to immunosuppressants analysis. Anal Bioanal Chem. 2015;407(6):1585\u201394.","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"5155_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/bcpt.13269","volume":"125","author":"KL Min","year":"2019","unstructured":"Min KL, Ryu JY, Chang MJ. Development and clinical applications of the dried blood spot method for therapeutic drug monitoring of anti-epileptic drugs. Basic Clin Pharmacol Toxicol. 2019;125(3):215\u201336.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"10","key":"5155_CR38","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4155\/bio.15.63","volume":"7","author":"RA Koster","year":"2015","unstructured":"Koster RA, et al. The performance of five different dried blood spot cards for the analysis of six immunosuppressants. Bioanalysis. 2015;7(10):1225\u201335.","journal-title":"Bioanalysis"},{"issue":"13","key":"5155_CR39","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4155\/bio-2023-0057","volume":"15","author":"B Thompson","year":"2023","unstructured":"Thompson B, et al. Application of novel plasma separation filter cards for quantification of nucleoside\/nucleotide reverse transcriptase inhibitor di\/triphosphates in dried blood spots using LC-MS. Bioanalysis. 2023;15(13):739\u201356.","journal-title":"Bioanalysis"},{"issue":"21","key":"5155_CR40","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.4155\/bio.13.227","volume":"5","author":"J Luckwell","year":"2013","unstructured":"Luckwell J, et al. Assessment of the within- and between-lot variability of Whatman\u2122 FTA(\u00ae) DMPK and 903(\u00ae) DBS papers and their suitability for the quantitative bioanalysis of small molecules. Bioanalysis. 2013;5(21):2613\u201330.","journal-title":"Bioanalysis"},{"issue":"5","key":"5155_CR41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/QAI.0b013e318159d7f4","volume":"46","author":"L Waters","year":"2007","unstructured":"Waters L, et al. Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2007;46(5):590\u20133.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1\u20132","key":"5155_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jviromet.2007.11.011","volume":"148","author":"CT Kane","year":"2008","unstructured":"Kane CT, et al. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J Virol Methods. 2008;148(1\u20132):291\u20135.","journal-title":"J Virol Methods"},{"issue":"1","key":"5155_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/QAI.0b013e3181aeccbc","volume":"52","author":"AD Mbida","year":"2009","unstructured":"Mbida AD, et al. Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon. J Acquir Immune Defic Syndr. 2009;52(1):9\u201316.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5155_CR44","unstructured":"Hologic I. Download package insert documents for Aptima HIV-1 Quant Dx Assay. Package Insert; AW-31085-001. 2024."},{"issue":"1","key":"5155_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/JCM.02853-15","volume":"54","author":"K Brooks","year":"2016","unstructured":"Brooks K, et al. HemaSpot, a novel blood storage device for HIV-1 drug resistance testing. J Clin Microbiol. 2016;54(1):223\u20135.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"5155_CR46","doi-asserted-by":"publisher","first-page":"e0030724","DOI":"10.1128\/spectrum.00307-24","volume":"12","author":"JM Fogel","year":"2024","unstructured":"Fogel JM, et al. Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiol Spectr. 2024;12(8):e0030724.","journal-title":"Microbiol Spectr"},{"issue":"13","key":"5155_CR47","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMc2402088","volume":"391","author":"RJ Landovitz","year":"2024","unstructured":"Landovitz RJ, et al. Features of HIV infection in the context of long-acting cabotegravir preexposure prophylaxis. N Engl J Med. 2024;391(13):1253\u20136.","journal-title":"N Engl J Med"},{"issue":"11","key":"5155_CR48","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1111\/bcp.16182","volume":"90","author":"AD Leino","year":"2024","unstructured":"Leino AD, et al. Clinical validation of two volumetric absorptive microsampling devices to support home-based therapeutic drug monitoring of immunosuppression. Br J Clin Pharmacol. 2024;90(11):2897\u2013909.","journal-title":"Br J Clin Pharmacol"},{"issue":"20","key":"5155_CR49","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4155\/bio-2022-0167","volume":"14","author":"KX Wan","year":"2022","unstructured":"Wan KX, et al. Bioanalytical method validation and sample analysis for nirmatrelvir in dried blood collected using the Tasso-M20 device. Bioanalysis. 2022;14(20):1305\u201315.","journal-title":"Bioanalysis"},{"issue":"1","key":"5155_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cpt.3025","volume":"115","author":"K Wan","year":"2024","unstructured":"Wan K, et al. Patient centric microsampling to support paxlovid clinical development: bridging and implementation. Clin Pharmacol Ther. 2024;115(1):42\u201351.","journal-title":"Clin Pharmacol Ther"},{"issue":"21","key":"5155_CR51","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.4155\/bio-2022-0189","volume":"14","author":"R Johnson","year":"2022","unstructured":"Johnson R, et al. Volumetric absorptive microsampling-LC-MS\/MS assays for quantitation of giredestrant in dried human whole blood. Bioanalysis. 2022;14(21):1377\u201389.","journal-title":"Bioanalysis"},{"issue":"4","key":"5155_CR52","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/acer.15024","volume":"47","author":"JD Jett","year":"2023","unstructured":"Jett JD, et al. Validation of the quantification of phosphatidylethanol 16:0\/18:1 concentrations in TASSO-M20 devices. Alcohol Clin Exp Res (Hoboken). 2023;47(4):748\u201355.","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"issue":"3","key":"5155_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/QAI.0000000000003570","volume":"98","author":"AS Devanathan","year":"2025","unstructured":"Devanathan AS, et al. A cross-biomeasure study to optimize antiretroviral adherence estimation. J Acquir Immune Defic Syndr. 2025;98(3):291\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5155_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/bcp.70234","volume":"91","author":"R Coyle","year":"2025","unstructured":"Coyle R, et al. TFV-DP and FTC\u2010TP using volumetric absorptive microsampling compared with DBS among persons receiving TDF\/FTC or TAF\/FTC. Br J Clin Pharmacol. 2025;91:23\u201323.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"5155_CR55","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10461-022-03846-8","volume":"27","author":"A Sharma","year":"2023","unstructured":"Sharma A, et al. Perceptions and experiences of returning self-collected specimens for HIV, bacterial STI and potential PrEP adherence testing among sexual minority men in the United States. AIDS Behav. 2023;27(4):1091\u2013105.","journal-title":"AIDS Behav"},{"issue":"7","key":"5155_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/OLQ.0000000000000778","volume":"45","author":"A Lockhart","year":"2018","unstructured":"Lockhart A, et al. Prospective evaluation of cervicovaginal self- and cervical physician collection for the detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium infections. Sex Transm Dis. 2018;45(7):488\u201393.","journal-title":"Sex Transm Dis"},{"issue":"13","key":"5155_CR57","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/diagnostics15131604","volume":"15","author":"K Reddy","year":"2025","unstructured":"Reddy K, et al. Validation of rapid point-of-care diagnostic tests for sexually transmitted infection self-testing among adolescent girls and young women. Diagnostics (Basel). 2025;15(13):1604.","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"5155_CR58","doi-asserted-by":"publisher","first-page":"e0264620","DOI":"10.1128\/JCM.02646-20","volume":"59","author":"EN Kersh","year":"2021","unstructured":"Kersh EN, et al. At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues. J Clin Microbiol. 2021;59(11):e0264620.","journal-title":"J Clin Microbiol"},{"key":"5155_CR59","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.jviromet.2020.113947","volume":"285","author":"L Garnett","year":"2020","unstructured":"Garnett L, et al. Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages. J Virol Methods. 2020;285:113947.","journal-title":"J Virol Methods"},{"issue":"6","key":"5155_CR60","doi-asserted-by":"publisher","first-page":"e68097","DOI":"10.1371\/journal.pone.0068097","volume":"8","author":"FS Dube","year":"2013","unstructured":"Dube FS, et al. Detection of Streptococcus pneumoniae from different types of nasopharyngeal swabs in children. PLoS ONE. 2013;8(6):e68097.","journal-title":"PLoS ONE"},{"issue":"3","key":"5155_CR61","doi-asserted-by":"publisher","first-page":"115455","DOI":"10.1016\/j.diagmicrobio.2021.115455","volume":"101","author":"TR Phillips","year":"2021","unstructured":"Phillips TR, et al. A comparison of cotton-tipped and nylon flocked swabs for culture of Neisseria gonorrhoeae from oropharyngeal samples. Diagn Microbiol Infect Dis. 2021;101(3):115455.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"5155_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1128\/JCM.02235-16","volume":"55","author":"J Moncada","year":"2017","unstructured":"Moncada J, et al. Stability studies on dry swabs and wet mailed swabs for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in aptima assays. J Clin Microbiol. 2017;55(3):971\u20137.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5155_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13568-020-00978-9","volume":"10","author":"AA Zasada","year":"2020","unstructured":"Zasada AA, et al. The influence of a swab type on the results of point-of-care tests. AMB Express. 2020;10(1):46.","journal-title":"AMB Express"},{"issue":"2","key":"5155_CR64","doi-asserted-by":"publisher","first-page":"102872","DOI":"10.1016\/j.amjoto.2020.102872","volume":"42","author":"V Bidkar","year":"2021","unstructured":"Bidkar V, et al. A comparison of swab types on sample adequacy, suspects comfort and provider preference in COVID-19. Am J Otolaryngol. 2021;42(2):102872.","journal-title":"Am J Otolaryngol"},{"issue":"22","key":"5155_CR65","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"issue":"11","key":"5155_CR66","doi-asserted-by":"publisher","first-page":"e25634","DOI":"10.1002\/jia2.25634","volume":"23","author":"ER Brown","year":"2020","unstructured":"Brown ER, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. J Int AIDS Soc. 2020;23(11):e25634.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"5155_CR67","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/infdis\/jiad535","volume":"229","author":"ED Weld","year":"2024","unstructured":"Weld ED, et al. Tenofovir douche as HIV preexposure prophylaxis for receptive anal intercourse: safety, acceptability, pharmacokinetics, and pharmacodynamics (DREAM 01). J Infect Dis. 2024;229(4):1131\u201340.","journal-title":"J Infect Dis"},{"issue":"4","key":"5155_CR68","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/infdis\/jiaf349","volume":"232","author":"JA Bauermeister","year":"2025","unstructured":"Bauermeister JA, et al. Safety, pharmacokinetics, and acceptability of a tenofovir rectal microbicide douche among young men who have sex with men: the DREAM ATN study (ATN 163). J Infect Dis. 2025;232(4):826\u201334.","journal-title":"J Infect Dis"},{"issue":"1","key":"5155_CR69","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10461-018-2211-5","volume":"23","author":"WS Aung","year":"2019","unstructured":"Aung WS, et al. Fecal coliform bacterial detection to assess enema adherence in HIV prevention clinical studies. AIDS Behav. 2019;23(1):252\u20138.","journal-title":"AIDS Behav"},{"issue":"1","key":"5155_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/QAI.0000000000001971","volume":"81","author":"M Gandhi","year":"2019","unstructured":"Gandhi M, et al. Brief report: validation of a urine tenofovir immunoassay for adherence monitoring to PrEP and ART and establishing the cutoff for a point-of-care test. J Acquir Immune Defic Syndr. 2019;81(1):72\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"5155_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/QAD.0000000000002395","volume":"34","author":"M Gandhi","year":"2020","unstructured":"Gandhi M, et al. Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings. Aids. 2020;34(2):255\u201360.","journal-title":"Aids"},{"issue":"12","key":"5155_CR72","doi-asserted-by":"publisher","first-page":"e26389","DOI":"10.1002\/jia2.26389","volume":"27","author":"B Gati Mirembe","year":"2024","unstructured":"Gati Mirembe B, et al. High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort. J Int AIDS Soc. 2024;27(12):e26389.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"5155_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4314\/ahs.v23i4.5","volume":"23","author":"G Muzanyi","year":"2023","unstructured":"Muzanyi G, et al. Isoniazid hair drug levels among TB patients as a tool to monitor adherence, exposure, and TB treatment outcomes and its acceptability in a multicultural setting. A narrative review. Afr Health Sci. 2023;23(4):28\u201334.","journal-title":"Afr Health Sci"},{"issue":"5","key":"5155_CR74","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jinf.2015.08.003","volume":"71","author":"E Angelakis","year":"2015","unstructured":"Angelakis E, et al. Doxycycline assay hair samples for testing long-term compliance treatment. J Infect. 2015;71(5):511\u20137.","journal-title":"J Infect"},{"issue":"1","key":"5155_CR75","doi-asserted-by":"publisher","first-page":"e83736","DOI":"10.1371\/journal.pone.0083736","volume":"9","author":"AY Liu","year":"2014","unstructured":"Liu AY, et al. Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP). PLoS ONE. 2014;9(1):e83736.","journal-title":"PLoS ONE"},{"issue":"5","key":"5155_CR76","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/acer.15063","volume":"47","author":"MK Firkey","year":"2023","unstructured":"Firkey MK, et al. Feasibility of remote self-collection of dried blood spots, hair, and nails among people with HIV with hazardous alcohol use. Alcohol Clin Exp Res (Hoboken). 2023;47(5):986\u201395.","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"5155_CR77","unstructured":"US Food and Drug Administration. Single use only blood lancet with an integral sharps injury prevention feature. 2026 [cited 2026 March 6]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K221131"},{"key":"5155_CR78","unstructured":"International Air Transport Association (IATA). Dangerous goods regulations. 2026 [cited 2026 March 6]. Available from: https:\/\/www.iata.org\/contentassets\/b08040a138dc4442a4f066e6fb99fe2a\/dgr-66-en-3.6.2.pdf"},{"key":"5155_CR79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.annepidem.2020.07.015","volume":"49","author":"AJ Siegler","year":"2020","unstructured":"Siegler AJ, et al. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response. Ann Epidemiol. 2020;49:50\u201360.","journal-title":"Ann Epidemiol"},{"key":"5155_CR80","unstructured":"ClinicaTrials.gov. Feasibility of remote data collection with a point of care device to measure HbA1c. 2026 [cited 2026 March 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05725746"},{"issue":"1","key":"5155_CR81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/25787489.2022.2103512","volume":"23","author":"MCD Stoner","year":"2022","unstructured":"Stoner MCD, et al. Digital directly observed therapy to monitor adherence to medications: a scoping review. HIV Res Clin Pract. 2022;23(1):47\u201360.","journal-title":"HIV Res Clin Pract"},{"key":"5155_CR82","unstructured":"ClinicaTrials.gov. HIV outpatient monitoring evaluation through self-collection of dried blood spots (HOME-1). 2026 [cited 2026 March 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04979728"},{"key":"5155_CR83","doi-asserted-by":"publisher","first-page":"101311","DOI":"10.1016\/j.pmedr.2021.101311","volume":"21","author":"KiA Sinclair","year":"2021","unstructured":"Sinclair KiA, et al. Increasing health equity through biospecimen research: Identification of factors that influence willingness of Native Americans to donate biospecimens. Prev Med Rep. 2021;21:101311.","journal-title":"Prev Med Rep"},{"issue":"3","key":"5155_CR84","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1891\/LGBTQ-2023-0045","volume":"5","author":"N Panyanouvong","year":"2024","unstructured":"Panyanouvong N, et al. The experiences of sexual and gender minority participants with a remote biospecimen collection protocol. Annals LGBTQ public Popul health. 2024;5(3):206.","journal-title":"Annals LGBTQ public Popul health"},{"key":"5155_CR85","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4132978\/v1","author":"JV Chavez","year":"2024","unstructured":"Chavez JV, et al. I was like sh*t this is gonna hurt\u2019: implementing self-sampling of dried blood spots to measure HIV viral load. Res Sq. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-4132978\/v1","journal-title":"Res Sq"},{"key":"5155_CR86","doi-asserted-by":"publisher","first-page":"113589","DOI":"10.1016\/j.jpeds.2023.113589","volume":"262","author":"KR MacDonald","year":"2023","unstructured":"MacDonald KR, et al. Ethical aspects of involving adolescents in HIV research: a systematic review of the empiric literature. J Pediatr. 2023;262:113589.","journal-title":"J Pediatr"},{"issue":"2","key":"5155_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1363\/psrh.12027","volume":"49","author":"B Mustanski","year":"2017","unstructured":"Mustanski B, et al. Sexual and gender minority adolescents\u2019 views on HIV research participation and parental permission: a mixed-methods study. Perspect Sex Reprod Health. 2017;49(2):111\u201321.","journal-title":"Perspect Sex Reprod Health"},{"key":"5155_CR88","doi-asserted-by":"publisher","first-page":"e56096","DOI":"10.2196\/56096","volume":"14","author":"A Aldredge","year":"2025","unstructured":"Aldredge A, et al. Preventing premature pre-exposure prophylaxis discontinuation and sexually transmitted infections among men who have sex with men (Project PEACH): protocol for a prospective cohort study. JMIR Res Protoc. 2025;14:e56096.","journal-title":"JMIR Res Protoc"},{"issue":"1","key":"5155_CR89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13063-024-08540-9","volume":"26","author":"ML Ybarra","year":"2025","unstructured":"Ybarra ML, et al. Sexual Health Advocacy for Guys (SHAG): a randomized trial of the impact of a text-messaging program on HIV incidence and STI testing among a national sample of sexual minority cisgender adolescent and young adult men. Trials. 2025;26(1):9.","journal-title":"Trials"},{"issue":"1","key":"5155_CR90","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13187-012-0421-5","volume":"28","author":"DO Erwin","year":"2013","unstructured":"Erwin DO, et al. Community-based partnership to identify keys to biospecimen research participation. J Cancer Educ. 2013;28(1):43\u201351.","journal-title":"J Cancer Educ"},{"issue":"4","key":"5155_CR91","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s10461-024-04599-2","volume":"29","author":"JL Walsh","year":"2025","unstructured":"Walsh JL, et al. Acceptability and feasibility of self-collected dried blood spot specimens for viral load monitoring among rural older people living with HIV. AIDS Behav. 2025;29(4):1247\u201355.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05155-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05155-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05155-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:11:02Z","timestamp":1779797462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05155-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":91,"alternative-id":["5155"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05155-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"18 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All other authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}